Manchester BRC researchers named in New Year’s Honours List
Two leading researchers from the NIHR Manchester BRC have been named on the 2018 New Year’s Honours List.
Professor Caroline Dive, the Deputy Director of the Cancer Research UK Manchester Institute, based at The University of Manchester has received a CBE for her services to cancer research.
Professor Dive is a world leader in developing ‘liquid biopsies’ to hunt cancer cells that have broken free from tumours and are circulating in the bloodstream. Her work on developing simple blood tests to capture cancer cells could help researchers understand how lung cancer changes as it grows and spreads, and how it can become resistant to treatment. In turn, this will open up opportunities to develop new therapies to treat this disease more effectively.
Explore the potential for Cancer Precision Medicine
Watch Professor Caroline Dive, Cancer Precision Medicine theme lead, provide an insight into her research.
Professor Dive leads the BRC’s Cancer Precision Medicine Theme, where researchers are developing a personalised medicine approached, targeting specific therapy to an individual’s cancer.
Professor Chris Griffiths has received the OBE for his contribution to dermatology. Professor Griffiths is Foundation Professor of Dermatology at The University of Manchester and Consultant Dermatologist at Salford Royal NHS Foundation Trust.
He has a particular interest in psoriasis and is Director of the MRC stratified medicine consortium – psoriasis stratification to optimise relevant therapy – (PSORT) and Chief Investigator of the national pharmacovigilance register for psoriasis – British Association of Dermatologists Biologic Interventions Register (BADBIR). He also leads a large research programme on skin ageing and is the founder of the skincare company CG Skin.
Find out about our dermatology research
Watch Professor Chris Griffiths, Dermatology theme lead, explain the research which lies ahead in the BRC.
Professor Griffiths leads the BRC’s Dermatology Theme, where work is underway to develop a greater understanding of the causes of skin and wound disorders and using this knowledge to deliver improved treatments, diagnosis and care.